Crestwood Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.52M Sell
19,717
-1,203
-6% -$319K 6.24% 8
2026
Q1
$2.29M Hold
20,920
1.58% 13
2025
Q4
$3.48M Hold
20,920
2.2% 11
2025
Q3
$4.1M Hold
20,920
2.85% 10
2025
Q2
$1.89M Hold
20,920
1.29% 13
2025
Q1
$1.25M Hold
20,920
0.96% 15
2024
Q4
$2.77M Hold
20,920
2.04% 13
2024
Q3
$1.1M Buy
20,920
+920
+5% +$43.2K 0.85% 15
2024
Q2
$1.21M Hold
20,000
0.86% 14
2024
Q1
$1.48M Buy
+20,000
New +$1.48M 0.92% 16

Other funds holding ALAB

Crestwood Capital Management's ALAB Position: Q2 2026 in Review

Crestwood Capital Management reduced its Astera Labs (ALAB) stake by 5.8% in Q2 2026, selling an estimated $319K and leaving 19,717 shares worth $9.52M. The position accounts for 6.24% of the portfolio, ranked #8.

Crestwood Capital Management first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Crestwood Capital Management held 19,717 shares of Astera Labs worth $9.52M as of Q2 2026.
  • Crestwood Capital Management sold 1,203 Astera Labs shares in Q2 2026, an estimated $319K.
  • Astera Labs made up 6.24% of Crestwood Capital Management's portfolio in Q2 2026, its #8 holding.
  • Crestwood Capital Management first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Crestwood Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.